EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pentosan polysulfate sodium for chronic bladder pain conditions: Real-world experiences from a tertiary care center

Dayan Jacob, George Hanna, Ahmed Ghonaimy, Sumathi Gelli, Emma Pattie, Wasim Mahmalji, Mehwash Nadeem

Bladder · 2025

DOI: 10.14440/bladder.0247 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bladder, 2025. Verfasst von Dayan Jacob und 6 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bladder pain syndrome (BPS) is a chronic condition characterized by pelvic pain and lower urinary tract symptoms. Pentosan polysulfate sodium (PPS) is the only oral therapy licensed in the United Kingdom (UK) for BPS; however, evidence on its effectiveness is inconsistent, with limited data for off-label use in ketamine- or radiation-induced cystitis.

Objective

This study evaluates real-world outcomes of PPS in patients with BPS and other chronic bladder pain at a UK tertiary center.

Methods

A retrospective review included 42 patients prescribed PPS between 2020 and 2024 for BPS (n = 29), ketamine-induced cystitis (n = 9), or radiation/chemotherapy-induced cystitis (n = 4), excluding Bacillus Calmette–Guérin cystitis. Demographics, comorbidities, prior treatments, symptom severity, and treatment response were recorded. Changes in quality of life (QoL) and Interstitial Cystitis Symptom Index/Interstitial Cystitis Problem Index (ICSI/ICPI) scores were analyzed using the Wilcoxon signed-rank test and one-way analysis of variance.

Results

The mean age was 49.7 years, and 81% were female, with a median follow-up of 15.3 months. All patients were severely symptomatic at baseline. Among those with follow-up data, 42.5% were asymptomatic, 25% mildly symptomatic, and 32.5% remained severely symptomatic. QoL improved significantly (Wilcoxon Z = −4.71, p

Zitieren

APA

Jacob, D., Hanna, G., Ghonaimy, A., Gelli, S., Pattie, E., Mahmalji, W., & Nadeem, M. (2025). Pentosan polysulfate sodium for chronic bladder pain conditions: Real-world experiences from a tertiary care center. Bladder. https://doi.org/10.14440/bladder.0247

Vancouver

Jacob D, Hanna G, Ghonaimy A, Gelli S, Pattie E, Mahmalji W, et al. Pentosan polysulfate sodium for chronic bladder pain conditions: Real-world experiences from a tertiary care center. Bladder. 2025. doi:10.14440/bladder.0247

BibTeX
@article{Jacob2025,
  author = {Jacob, Dayan and Hanna, George and Ghonaimy, Ahmed and Gelli, Sumathi and Pattie, Emma and Mahmalji, Wasim and Nadeem, Mehwash},
  title = {Pentosan polysulfate sodium for chronic bladder pain conditions: Real-world experiences from a tertiary care center},
  journal = {Bladder},
  year = {2025},
  doi = {10.14440/bladder.0247}
}
Kostenlos starten →